Predict your next investment

HEALTHCARE | Drug Development
proventionbio.com

See what CB Insights has to offer

Stage

IPO | IPO

Total Raised

$28.45M

Date of IPO

7/24/2018

Market Cap

0.48B

Stock Price

6.20

About Provention Bio

Provention Bio is a clinical-stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics and solutions to intercept and prevent immune-mediated disease. The company's founding mission is to in-license and develop clinical-stage, or nearly clinical-stage product candidates to reduce the high-morbidity/mortality and escalating costs of autoimmune and inflammatory diseases, such as type 1 diabetes, Crohn's disease, ulcerative colitis and emerging viruses. Its pioneering approach is to "predict" and "pre-empt" immune-mediated disease – to identify at-risk patients and intervene before the targeted disease begins, re-appears or progresses.

Provention Bio Headquarter Location

55 Broad St 2nd Floor

Red Bank, New Jersey, 07701,

United States

908-428-9136

Latest Provention Bio News

Provention Bio To Present At The Cantor Fitzgerald Virtual Global Healthcare Conference 2021

Sep 23, 2021

Provention Bio To Present At The Cantor Fitzgerald Virtual Global Healthcare Conference 2021 RED BANK, N.J. Sep 23, 2021 7:30 AM EDT RED BANK, N.J., Sept. 23, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that management will participate in a fireside chat presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference 2021 on Wednesday, September 29, 2021 at 3:20 pm E.T. The fireside chat will be webcast live and can be accessed by visiting the Events and Webcasts section of the Company's website: http://investors.proventionbio.com/events . The webcast will be archived on the Company's website for 30 days following the presentation. About Provention Bio, Inc.: Provention Bio, Inc. (Nasdaq: PRVB) is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company's pipeline includes clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in autoimmune diseases, including type 1 diabetes, celiac disease and lupus. Visit www.ProventionBio.com for more information and follow us on Twitter: @ProventionBio. Internet Posting of Information: Provention Bio, Inc. uses its website,  www.proventionbio.com , as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation F.D. Such disclosures will be included on the Company's website in the "News" section. Accordingly, investors should monitor this portion of the Company's website, in addition to following its press releases, SEC filings and public conference calls and webcasts. Investor Contacts: Sam Martin, Argot Partners proventionbio@argotpartners.com    212-600-1902 Media Contact: Lori Rosen, LDR Communications lori@ldrcommunications.com 917-553-6808 View original content to download multimedia: https://www.prnewswire.com/news-releases/provention-bio-to-present-at-the-cantor-fitzgerald-virtual-global-healthcare-conference-2021-301383432.html SOURCE Provention Bio, Inc.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Provention Bio

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Provention Bio is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

14,138 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

D

Diabetes

1,750 items

Provention Bio Patents

Provention Bio has filed 3 patents.

The 3 most popular patent topics include:

  • Immunology
  • Monoclonal antibodies
  • Clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/7/2021

Immunology, Vaccines, Clusters of differentiation, Immune system, Monoclonal antibodies

Application

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/7/2021

00/00/0000

00/00/0000

Grant Date

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Immunology, Vaccines, Clusters of differentiation, Immune system, Monoclonal antibodies

Subscribe to see more

Subscribe to see more

Status

Application

Subscribe to see more

Subscribe to see more

Provention Bio Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Provention Bio Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.